SCHEMBL7591756

SCHEMBL7591756

O=C(O)c1cc2ccccc2c(C(=O)c2cc3ccccc3cn2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGFBP3 P17936 11/20 0.50
EGLN1 Q9GZT9 1/20 0.43
IGFBP1 P08833 1/20 0.42
IGFBP2 P18065 1/20 0.42
IGFBP4 P22692 1/20 0.42
IGFBP6 P24592 1/20 0.42
IGFBP5 P24593 1/20 0.42
KMT2A Q03164 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9327979 0.81 IGFBP3 (0.52) IGFBP3IGFBP1IGFBP2IGFBP4IGFBP6
SCHEMBL155043 0.81 EGLN1 (0.54) EGLN1KMT2AGABRPGABRDGABRA1
SCHEMBL29489052 0.81 EGLN1 (0.54) EGLN1KMT2AGABRPGABRDGABRA1
SCHEMBL29746814 0.81 EGLN1 (0.54) EGLN1KMT2AGABRPGABRDGABRA1
SCHEMBL3205661 0.80 IGFBP3 (0.49) IGFBP3IGFBP1IGFBP2IGFBP4IGFBP6
SCHEMBL27360353 0.79 EGLN1 (0.53) EGLN1KMT2AGABRPGABRDGABRA1
Hydrochloric Acid SCHEMBL27469719 0.79 EGLN1 (0.53) EGLN1KMT2AGABRPGABRDGABRA1
Water SCHEMBL1201320 0.79 EGLN1 (0.53) EGLN1KMT2AGABRPGABRDGABRA1
Methyl Alcohol SCHEMBL28240452 0.77 EGLN1 (0.51) EGLN1KMT2AGABRPGABRDGABRA1
Hydrochloric Acid SCHEMBL28181942 0.77 EGLN1 (0.51) EGLN1KMT2AGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263454-A2 METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG Praecis Pharmaceuticals Incorporated (US) 2002-12-11 EP disclosed
WO-2000052048-A9 MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARM INC (US) 2002-04-11 WO disclosed
EP-1161449-A1 MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS Praecis Pharmaceuticals Incorporated (US) 2001-12-12 EP disclosed
WO-2001058470-A2 METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG PRAECIS PHARMACEUTICALS INCORPORATED (US) 2001-08-16 WO disclosed
WO-2000052048-A1 MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARMACEUTICALS INCORPORATED (US) 2000-09-08 WO disclosed
EP-0929574-A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS Praecis Pharmaceuticals Incorporated (US) 1999-07-21 EP disclosed
WO-1998008868-A9 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS 1998-05-28 WO disclosed
WO-1998008868-A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARMACEUTICALS INCORPORATED (US) 1998-03-05 WO disclosed